Utilizing the Molecular/Physiologic Phenotype to Direct Asthma Therapy: A Comprehensive 3-Dimensional Study
Thursday, November 15, 2018
6:00PM – 6:30 PM Dinner/Registration
6:30PM – 8:00 PM CME Presentation
Sheraton Seattle Hotel
1400 6th Ave, Seattle, WA 98101
Meeting Room: Metropolitan Ballroom, Salon B – 3rd FL
- Create your own Personalized Poster
- Interactive, case-based learning environment
- 3D videos and glasses for all attendees
Jonathan Corren, MD
Director Allergy Medical Center
Associate Professor Department of Internal Medicine
UCLA Medical Center
Los Angeles, CA
Michael E. Wechsler, MD, MMSc
Director, Asthma Program
Department of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health
After completing the CME activity, learners should be better able to:
- Assess the causes of underlying inflammation in asthma, and resulting targets of therapy
- Evaluate the level of asthma control, disease severity, and exacerbation risk to better drive appropriate treatment
- Review currently-available and novel targeted therapies and their effect on treatment strategies for patients with moderate-to-severe asthma
This CME initiative is designed to meet the educational needs of pulmonologists, allergists, immunologists and primary care physicians who are involved in the healthcare of patients with severe asthma.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Feel free to pass this invitation on to your physicians, fellows, physician assistants, nurses, pharmacists, healthcare practitioners, and any other colleagues that you believe would be interested in attending this free CME/CNE program.
Copyright © 2018 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.